Clinical Trial Detail

NCT ID NCT01411410
Title Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

Advanced Solid Tumor

Therapies

Copanlisib + Paclitaxel

Age Groups: senior adult

No variant requirements are available.